Big Move For Theseus Pharmaceuticals Inc.
Wed, Jan 04, 2023 at 07:00 PM
Theseus Pharmaceuticals Inc. (THRX:NASDAQ) rocketted at $7.1, representing a gain of 36.3%. On Wed, Jan 04, 2023, THRX:NASDAQ hit a New 2-Week High of $7.1. The stock appeared on our News Catalysts scanner on Thu, Dec 15, 2022 at 03:13 AM in the 'BIOTECH' category. From Wed, Dec 21, 2022, the stock recorded 50.00% Up Days and 55.56% Green Days
About Theseus Pharmaceuticals Inc. (THRX:NASDAQ)
Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted...
Top 10 Gainers:
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 154.05%
- Cryptyde Inc. (TYDE:NASDAQ), 81.35%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 70.05%
- Shift Technologies Inc. (SFT:NASDAQ), 57.5%
- Relativity Acquisition Corp. (RACY:NASDAQ), 47.65%
- eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 44.9%
- Elys Game Technology Corp. (ELYS:NASDAQ), 39.96%
- Reunion Neuroscience Inc. (REUN:NASDAQ), 39.42%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 37.72%
- Theseus Pharmaceuticals Inc. (THRX:NASDAQ), 36.28%